Dr. rer. nat. Lennart Lenk

Facts

Affiliations: Clinic for Pediatrics and Adolescent Medicine I / University Medical Center Schleswig-Holstein, Campus Kiel
Address: Arnold-Heller-Str. 3, QFZ (Haus U18) 24105 Kiel

Curriculum Vitae

Research Experience

Since 05/2017Research associate/Co-group leader “Translational ALL-research”, Department of Pediatric and Adolescent Medicine I, Section Pediatric Hematology / Oncology, University Medical Center Schleswig-Holstein (UKSH), Campus Kiel
Since 2014Independent medical communication designer/consultant
07/2013 – 04/2017Research associate, Institute for Experimental Cancer Research (IET), UKSH Kiel

Education/Training

07/2013 –
08/2017
PhD student (Dr. rer. nat), Institute for Experimental Cancer Research, UKSH Kiel
10/2008 – 08/2017Studies of biology, Christian Albrechts University Kiel

Awards

2022ASH Achievement Award, 63rd ASH Annual Meeting, New Orleans, LA, US
2018ASH Achievement Award, 60th ASH Annual Meeting, San Diego, CA, US
2015DPC Travel stipend 35. Annual convention of the German Pancreas Club, Rostock

Project-related publications

P1, P3, P6, P7, Z

The IL-7R antagonist Lusvertikimab reduces leukemic burden in xenograft-ALL via antibody-dependent cellular phagocytosis

Lenk L, Baccelli I, Laqua A, Heymann J, Reimer C, Dietterle A, Winterberg D, Mary C, Corallo F, Taurelle J, Narbeburu E, Neyton SL, Déramé M, Pengam S, Vogiatzi F, Bornhauser B, Bourquin JP, Raffel S, Dovhan V, Schüler T, Escherich G, den Boer ML, Boer JM, Wessels W, Peipp M, Alten J, Antić Ž, Bergmann AK, Schrappe M, Cario G, Brüggemann M, Poirier N, Schewe DM.

Participating Institutes